Abstract
The regulation of redox homeostasis and the reduction of oxidative stress is one of several strategies used in the development of anticancer drugs. Understanding from in silico studies, how a particular molecule binds to the receptor, allows the selection of promising compounds that may be used in antineoplastic pharmacotherapy. Protein–ligand coupling can use the study and relationship between the protein–ligand complex or that is the origin of the ligand-target interaction. The docking algorithms used present a high complexity; however, currently, the systems used to perform such studies present a friendly interface. A comparative study of various coupling algorithms can provide us with useful information to select the appropriate algorithm for drug research, design, and selection using new computational techniques. Hence, from this perspective, the purpose of this chapter is to provide new information about how it is possible to study via docking molecular Reactive Oxygen Species (ROS) enzymes against antineoplastic agents and to associate them with antitumor pharmacotherapy. The performed molecular docking results will be shown both the lower binding affinity (∆G) values for the receptor-ligand, as well as interactions in the two enzymes, obtained after validation of the molecular docking protocols for the receptors: cytochrome P450 (CYP450) and NADPH oxidase (NOX).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Silva, A.A., Gonçalves, R.C.: Espécies reativas de oxigênio e as doenças do trato respiratório de grandes animais. Ci ê ncia Rural 40, 994–1002 (2010). [CrossRef]
Yun, J., Mullarky, E., Lu, C., Bosch, K.N., Kavalier, A., Rivera, K., Roper, J., Chio, I.I., Giannopoulou, E.G., Rago, C. et al.: Vitamina C mata seletivamente kras e braf mutante colorretal células cancerosas, visandoGAPdh. Ciência 350, 1391–1396 (2015). [CrossRef] [PubMed]
Branco, P.A., Oliveira, R.C., Oliveira, A.P., Serafini, M.R., Araújo, A.A., Gelain, D.P., Moreira, J.C., Almeida, Jr. R., Quintans, J.S., Quintans-Junior, L.J., et al.: Atividade antioxidante e mecanismos de ação de compostos naturais isolados de líquens: Uma revisão sistemática. Moléculas 19, 14496–14527 (2014). [CrossRef][PubMed]
Reuter, S., Gupta, S.C., Chaturvedi, M.M., Aggarwal, B.B.: Estresse oxidativo, inflamação e câncer: Como eles estão ligados? Radic livre. Biol. Med. 49,1603–1616 (2010). [CrossRef] [PubMed]
Cadenas, E.: Mecanismos básicos de atividade antioxidante. BioFatores 6, 391–397 (1997). [CrossRef] [PubMed]
Dharmaraja, A.T.: Papel das espécies reativas de oxigênio (ROS) na terapêutica e resistência a medicamentos em câncer e bactérias. Química. 60, 3221–3240 (2017). [CrossRef] [PubMed]
Gupta, M., Sharma, R., Kumar, A.: Técnicas de acoplamento em farmacologia: Quanto promissor? Comp. Biol. Chem. 76, 210–217 (2018). [CrossRef] [PubMed]
Zheng, M., Liu, Z., Yan, X., Ding, Q., Gu, Q., Xu, J.: LBVS: an online platform for ligand-based virtual screening using publicly accessible databases. Mol. Diversity 18(4), 829–840 (2014). https://doi.org/10.1007/s11030-014-9545-3
Bento, A.P., Gaulton, A., Hersey, A., Bellis, L.J., Chambers, J., Davies, M., Krüger, F.A., Light, Y., Mak, L., McGlinchey, S., Nowotka, M., Papadatos, G., Santos, R., Overington, J.P.: Nucleic Acids Res. 42, D1083 (2014)
Sterling, T., Irwin, J. J., J. Chem. Inf. Model. 55, 2324 (2015)
Kim, S., Thiessen, P.A., Bolton, E.E., Chen, J., Fu, G., Gindulyte, A., Han, L., He, J., He, S., Shoemaker, B.A., Wang, J., Yu, B., Zhang, J., Bryant, S.H.: Nucleic Acids Res. 44, D1202 (2016)
Wang, R., Fang, X., Lu, Y., Wang, S., J. Med. Chem. 47, 2977 (2004)
Olah, M., Mracec, M., Ostopovici, L., Rad, R., Bora, A., Hadaruga, N., Olah, I., Banda, M., Simon, Z., Mracec, M., Oprea, T.I.: In: Oprea, T. I. (ed.) Em Chemoinformatics in Drug Discovery, Wiley-VCH Verlag GmbH & Co. KGaA: Weinheim, cap. 9 (2005)
Wishart, D.S.: Nucleic Acids Res. 34, D668 (2006)
Weininger, D.J.: SMILES, a chemical language and information system. J. Chem. Inf. Comput. Sci. 28, 31–36 (1988)
Dalby, A., Nourse, J.G., Hounshell, W.D., Gushurst, A.K.I., Grier, D.L., Leland, B.A., Laufer, J.: Description of several chemical structure file formats used by computer programs developed at molecular design limited. J. Chem. Inf. Model. 32(3), 244 (1992). https://doi.org/10.1021/ci00007a012
Berman, H.M.: The protein data bank: a historical perspective. Acta Crystallogr. A 64(1), 88–95 (2007)
Bajusz, D., Rácz, A., Héberger, K.: Why is Tanimoto index an appropriate choice for fingerprint-based similarity calculations? J. Cheminf. 7(1), 20 (2015)
Lipinski, C.A.: Drug-like properties andthe causes of poor solubility and poor permeability. J. Pharmacol Toxicol Methods 44(1), 235–249 (2000)
Kim, S., Thiessen, P.A., Bolton, E.E., Chen, J., Fu, G., Gindulyte, A., Han, L., He, J., He, S., Shoemaker, B.A., et al.: PubChem substance and compound databases. Nucleic Acids Res. 44, D1202–D1213 (2016)
Wang, Y., Bryant, S.H., Cheng, T., Wang, J., Gindulyte, A., Shoemaker, B.A., Thiessen, P.A., He, S., Zhang, J.: PubChem bioAssay: 2017 update. Nucleic Acids Res. 45, D955–D963 (2017)
Kim, S.: Getting the most out of PubChem for virtual screening. Expert Opin. Drug Discov. 11, 843–855 (2016)
Hahnke, V.D., Kim, S., Bolton, E.E.: PubChem chemical ¨structure standardization. J. Cheminform. 10, 36 (2018)
Kim, S., Thiessen, P.A., Cheng, T., Yu, B., Shoemaker, B.A., Wang, J.Y., Bolton, E.E., Wang, Y.L., Bryant, S.H.: Literature information in PubChem: associations between PubChem records and scientific articles. J. Cheminform. 8, 32 (2016)
Wang, Y., Xiao, J., Suzek, T.O., Zhang, J., Wang, J., Zhou, Z., Han, L., Karapetyan, K., Dracheva, S., Shoemaker, B.A., Bolton, E., Gindulyte, A., Bryant, S.H.: PubChem’s bioassay database. Nucleic Acids Res. 40(Database issue): D400–D412 (2012). https://doi.org/10.1093/nar/gkr1132
Kim, S., Chen, J., Cheng, T., Gindulyte, A., He, J., He, S., Li, Q., Shoemaker, B.A., Thiessen, P.A., Yu, B., Zaslavsky, L., Zhang, J., Bolton, E.E.: PubChem 2019 update: improved access to chemical data. Nucleic Acids Res. 47(D1), D1102-1109 (2019). https://doi.org/10.1093/nar/gky1033. [PubMed PMID: 30371825]
Gilson, M.K., Liu, T., Baitaluk, M., Nicola, G., Hwang, L., Chong, J.: BindingDB in 2015: a public database for medicinal chemistry, computational chemistry and systems pharmacology. Nucleic Acids Res. 44(D1), D1045–D1053 (2016). https://doi.org/10.1093/nar/gkv1072
Davies, M., Nowotka, M., Papadatos, G., Dedman, N., Gaulton, A., Atkinson, F., Bellis, L., Overington, J.P.: ChEMBL web services: streamlining access to drug discovery data and utilities. Nucleic Acids Res. 43(W1), W612–W620 (2015). https://doi.org/10.1093/nar/gkv352
Liu, T., Lin, Y., Wen, X., Jorissen, R.N., Gilson, M.K.: BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities. Nucleic. Acids Res. 35(Database), D198–D201 (2007). https://doi.org/10.1093/nar/gkl999
Gaulton, A., Hersey, A., Nowotka, M., Bento, A.P., Chambers, J., Mendez, D., Mutowo, P., Atkinson, F., Bellis, L.J., Cibrián-Uhalte, E., Davies, M., Dedman, N., Karlsson, A., Magariños, M.P., Overington, J.P., Papadatos, G., Smit, I., Leach, A.R.: The ChEMBL database in 2017. Nucleic Acids Res. 45(D1), D945–D954 (2016). https://doi.org/10.1093/nar/gkw1074
Gilson, M.K., Liu, T., Baitaluk, M., Nicola, G., Hwang, L., Chong, J.: BindingDB in 2015: A public database for medicinal chemistry, computational chemistry and systems pharmacology. Nucleic Acids Res. 44, D1045–D1063 (2016)
Liu, T., Lin, Y., Wen, X., Jorrisen, R.N., Gilson, M.K.: BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities. Nucleic Acids Res. 35, D198-D201 (2007)
Chen,X., Lin,Y., Gilson, M.K.: The binding database: overview and user's guide. Biopolym. Nucleic Acid Sci. 61,127-141 (2002)
Chen, X., Lin, Y., Liu, M., Gilson, M.K.: The binding database: data management and interface design. Bioinformatics 18, 130–139 (2002)
Chen, X., Liu, M., Gilson, M.K.: Binding DB: a web-accessible molecular recognition database. J. Combi. Chem. High-Throughput Screen 4, 719–725 (2001)
Sterling and Irwin, J. Chem. Inf. Model, (2015). http://pubs.acs.org/doi/abs/https://doi.org/10.1021/acs.jcim.5b00559
. Wishart, D.S., Feunang, Y.D., Guo, A.C., Lo, E.J., Marcu, A., Grant, J.R., Sajed, T., Johnson, D., Li, C., Sayeeda, Z., Assempour, N., Iynkkaran, I., Liu, Y., Maciejewski, A., Gale, N., Wilson, A., Chin, L., Cummings, R., Le, D., Pon, A., Knox, C., Wilson, M.: DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2017 Nov 8 (2017). https://doi.org/10.1093/nar/gkx1037
Costa, J.S., Ramos, R.S., Costa, K.S.L., Brasil, D.S.B., Silva, C.H.T.P., Ferreira, E.F.B., Borges, R.S., Campos, J.M., Macêdo, W.J.C., Santos, C.B.R.: An In silico study of the antioxidant ability for two caffeine analogs using molecular docking and quantum chemical methods. Molecules 23(11), 2801 (2018)
Gunes, A., Coskun, U., Boruban, C., Gunel, N., Babaoglu, M.O., Sencan, O., Bozkurt, A., Rane, A., Hassan, M., Zengil, H., et al.: Inhibitory effect of 5-fluorouracil on cytochrome P450 2C9 activity in cancer patients. Basic Clin. Pharmacol. Toxicol. 98, 197–200 (2006). [CrossRef] [PubMed]
Drugbank (2020). Available online: https://www.drugbank.ca/unearth/(accessed on 3 mach 2020)
Liu, S.L., Li, Y.H., Shi, G.Y., Tang, S.H., Jiang, S.J., Huang, C.W., Liu, P.Y., Hong, J.S., Wu, H.L.: Dextromethorphan reduces oxidative stress and inhibits atherosclerosis and neointima formation in mice.Cardiovasc. Res. 82, 161–169 (2009). [CrossRef] [PubMed]
Wu, T.C., Chao, C.Y., Lin, S.J., Chen, J.W.: Low-dose dextromethorphan, a NADPH oxidase inhibitor, reduces blood pressure and enhances vascular protection in experimental hypertension. PLoS ONE 9, 1–12 (2012). [CrossRef] [PubMed]
Anzenbacher, P., Anzenbacherova, E.: Cytochromes P450 and metabolism of xenobiotics. Cell. Mol. Life Sci. 58, 737–747 (2001)
Hodgson, J.: ADMET–turning chemicals into drugs. Nature Biotechnol. 19, 722–726 (2001)
Takahashi, H., Echizen, H.: Pharmacogenetics of warfarin elimination and its clinical implications. Clin. Pharmacokinet. 40, 587–603 (2001)
Kaminsky, L.S., Zhang, Z.Y.: Human P450 metabolism of warfarin. Pharmacol. Ther. 73, 67–74 (1997)
Williams, P.A., Cosme, J., Ward, A., Angove, H.C., Matak Vinković, D., Jhoti, H.: Crystal structure of human cytochrome P450 2C9 with bound warfarin. Nature 424(6947), 464–468 (2003). https://doi.org/10.1038/nature01862
Vlahos, R., Stambas, J., Bozinovski, S., Broughton, B.R.S., Drummond, G.R., Selemidis, S.: Inhibition of Nox2 oxidase activity ameliorates influenza A Virus-Induced Lung Inflammation. PLoS Pathog. 7(2), e1001271 (2011). https://doi.org/10.1371/journal.ppat.1001271
Selemidis, S., Sobey, C.G., Wingler, K., Schmidt, H.H., Drummond, G.R.: NADPH oxidases in the vasculature: molecular features, roles in disease and pharmacological inhibition. Pharmacol Ther 120, 254–291 (2008)
Bedard, K., Krause, K.H.: The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87, 245–313 (2007)
Lountos, G.T., Jiang, R., Wellborn, W.B., Thaler, T.L., Bommarius, A.S., Orville, A.M.: The crystal structure of NAD(P)H oxidase fromLactobacillus sanfranciscensis: insights into the conversion of O2into two water molecules by the flavoenzyme†,‡. Biochemistry 45(32), 9648–9659 (2006). https://doi.org/10.1021/bi060692p
Dallakyan, S., Olson, A.J.: Small-molecule library screening by docking with PyRx. Methods Mol. Bio. 1263, 243–250 (2015)
Morris, G.M., Goodsell, D.S., Halliday, R.S., Huey, R., Hart, W.E., Belew, R.K., Olson, A.J.: Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J. Comp. Chem. 19, 1639–1662 (1998). [CrossRef]
Trott, O., Olson, A.J.: AutoDock Vina: improving the speed and accuracy of docking with a new scoring function efficient optimization and multithreading. J. Comput. Chem. 31, 455–461 (2010)
Morris, G.M., Huey, R., Lindstrom, W., Sanner, M.F., Belew, R.K., Goodsell, D.S., Olson, A.J. (2009)
Dassault Systèmes BIOVIA, Discovery Studio Modeling Environment. Release 2017. Dassault Systèmes: San Diego, CA, USA, (2019)
Trott, O., Olson, A.J.: AutoDock Vina: improving the speed and accuracy of docking with a new scoring function efficient optimization and multithreading. National Institute of Health 31(2), 455–461 (2010)
Wang, R., Lai, L., Wang, S.: Further development and validation of empirival scoring functions for structure-based binding affinity prediction. J. Comput. Aided Mol. Des. 16(1), 11–26 (2002)
Aggarwal, R., Koes, D.R.: Learning RMSD to improve protein-ligand scoring and pose selection. ChemRxiv (2020). Preprint. https://doi.org/10.26434/chemrxiv.11910870.v2
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Macêdo, W.J.C. et al. (2021). High-Throughput-Based Virtual Screening via Molecular Docking for Oxidative Stress Mediated by ROS Enzyme. In: La Porta, F.A., Taft, C.A. (eds) Functional Properties of Advanced Engineering Materials and Biomolecules. Engineering Materials. Springer, Cham. https://doi.org/10.1007/978-3-030-62226-8_17
Download citation
DOI: https://doi.org/10.1007/978-3-030-62226-8_17
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-62225-1
Online ISBN: 978-3-030-62226-8
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)